GENERAL ATLANTIC, L.P. Q1 2025 Filing

Filed May 14, 2025

Portfolio Value

$3.0T

Holdings

15

Report Date

Q1 2025

Filing Type

13F-HR

All Holdings (15 positions)

#StockSharesValue% PortfolioType
1
ALHCALIGNMENT HEALTHCARE
60,993,323$1.1T38.12%
2
DLODLOCAL
63,906,695$533.0B17.89%
3
XPXP, INC
29,617,733$407.2B13.67%
4
ALKTALKAMI
9,645,318$253.2B8.50%
5
AKROAKERO THERAPEUTICS
5,233,989$211.9B7.11%
6
CNTACENTESSA PHARMACEUTICALS
9,681,818$139.2B4.67%
7
PHVSPHARVARIS
7,531,252$118.2B3.97%
8
EWCZEUROPEAN WAX CENTER
13,110,492$51.8B1.74%
9
RPRXROYALTY PHARMA
1,500,000$46.7B1.57%
10
IMCRIMMUNOCORE
1,261,684$37.4B1.26%
11
RSKDRISKIFIED
5,324,998$24.6B0.83%
12
SLRNACELYRIN
2,695,327$6.7B0.22%
13
ADAGADAGENE
3,825,952$5.8B0.20%
14
5ZZ0WISH
609,616$4.3B0.14%
15
GROVGROVE COLLABORATIVE
2,474,859$3.3B0.11%